We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+25.21%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$13.9M
AUM Growth
-$44.5M
Cap. Flow
-$44.7M
Cap. Flow %
-320.95%
Top 10 Hldgs %
48.07%
Holding
80
New
14
Increased
3
Reduced
23
Closed
39
Avg Time Held Equity + Options
3.3 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.9 quarters
Avg Time Held Equity only
3.3 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$510K
2
ELV icon
Elevance Health
ELV
+$459K
3
HUM icon
Humana
HUM
+$427K
4
CNC icon
Centene
CNC
+$371K
5
PFE icon
Pfizer
PFE
+$281K

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$2.23M
2
MCHP icon
Microchip Technology
MCHP
+$2.23M
3
ZBH icon
Zimmer Biomet
ZBH
+$1.99M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.81M
5
TWLO icon
Twilio
TWLO
+$1.74M

Sector Composition

Rank Sector Weight
1 Healthcare 99.1%
2 Miscellaneous 0.9%
3 Communication Services 0%
4 Consumer Discretionary 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IMMU
26
DELISTED
Immunomedics Inc
IMMU
$230K 1.65%
+10,880
New +$192K
2019 Q4
0 quarters
ABT icon
27
Abbott
ABT
$178B
$223K 1.6%
+2,565
New +$215K
2019 Q4
0 quarters
MOH icon
28
Molina Healthcare
MOH
$10.9B
$188K 1.35%
1,387
-5,796
-81% -$730K
2016 Q2
14 quarters
EW icon
29
Edwards Lifesciences
EW
$49.1B
$184K 1.32%
2,364
-8,793
-79% -$687K
2014 Q4
20 quarters
LAB icon
30
Standard BioTools
LAB
$259M
$132K 0.95%
37,856
+2,504
+7% +$8.81K
2019 Q1
3 quarters
CTLT icon
31
DELISTED
CATALENT, INC.
CTLT
$126K 0.9%
2,231
-11,331
-84% -$578K
2019 Q2
2 quarters
ABBV icon
32
AbbVie
ABBV
$485B
$112K 0.8%
+1,269
New +$105K
2019 Q4
0 quarters
AXNX icon
33
DELISTED
Axonics, Inc. Common Stock
AXNX
$110K 0.79%
3,978
+2,041
+105% +$48.7K
2019 Q3
1 quarter
CSII
34
DELISTED
Cardiovascular Systems, Inc.
CSII
$96K 0.69%
1,985
-3,930
-66% -$179K
2016 Q3
13 quarters
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$123B
$95K 0.68%
+434
New +$87.8K
2019 Q4
0 quarters
HALO icon
36
Halozyme
HALO
$12.4B
$82K 0.59%
+4,650
New +$80.5K
2019 Q4
0 quarters
AMRN icon
37
Amarin Corp
AMRN
$245M
$81K 0.58%
+188
New +$71.4K
2019 Q4
0 quarters
CHRS icon
38
Coherus Oncology
CHRS
$165M
$68K 0.49%
3,771
-4,035
-52% -$74.4K
2019 Q1
3 quarters
ACOR
39
DELISTED
Acorda Therapeutics
ACOR
$37K 0.27%
153
-13
-8% -$3.28K
2019 Q3
1 quarter
ELGX
40
DELISTED
Endologix Inc
ELGX
$4K 0.03%
2,440
-442
-15% -$1.24K
2019 Q3
1 quarter
AMD icon
41
Advanced Micro Devices
AMD
$989B
– –
-25,859
Closed -$750K –
BABA icon
42
Alibaba
BABA
$276B
– –
-2,532
Closed -$423K –
CRM icon
43
Salesforce
CRM
$196B
– –
-10,032
Closed -$1.49M –
DXCM icon
44
DexCom
DXCM
$32.1B
– –
-21,292
Closed -$794K –
EQ icon
45
Equillium
EQ
$83.7M
– –
-5,333
Closed -$20K –
FATE icon
46
Fate Therapeutics
FATE
$240M
– –
-8,899
Closed -$138K –
GDDY icon
47
GoDaddy
GDDY
$13B
– –
-21,910
Closed -$1.45M –
GS icon
48
Goldman Sachs
GS
$260B
– –
-1,562
Closed -$324K –
INSP icon
49
Inspire Medical Systems
INSP
$1.99B
– –
-3,549
Closed -$217K –
INTU icon
50
Intuit
INTU
$80.6B
– –
-5,722
Closed -$1.52M –
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Partner Investment Management held 80 positions worth $13.9M, down 76% from $58.4M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Partner Investment Management withdrew a net $44.7M in Q4 2019, closing 39 positions and reducing 23 holdings. Its most notable exit was NXP Semiconductors, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 53% a quarter earlier, followed by Miscellaneous and Communication Services.

Against the trend, Partner Investment Management opened a new position in Biogen worth $546K.

  • Partner Investment Management's largest Q4 2019 buy was Biogen: 1,839 shares worth $546K.
  • Partner Investment Management added most to Axonics, Inc. Common Stock in Q4 2019, an estimated $48.7K increase.
  • Partner Investment Management's biggest Q4 2019 reduction was Zimmer Biomet, cutting an estimated $1.99M.
  • Partner Investment Management fully exited NXP Semiconductors in Q4 2019, selling an estimated $2.23M.
  • Partner Investment Management's ten largest holdings make up 48% of its $13.9M portfolio in Q4 2019.
  • Partner Investment Management opened 14 new positions and closed 39 in Q4 2019.
  • Partner Investment Management's portfolio value fell 76% quarter-over-quarter to $13.9M.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.